RET tyrosine kinase signaling in development and cancer

E Arighi, MG Borrello, H Sariola - Cytokine & growth factor reviews, 2005 - Elsevier
The variety of diseases caused by mutations in RET receptor tyrosine kinase provides a
classic example of phenotypic heterogeneity. Gain-of-function mutations of RET are …

RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors

JWB de Groot, TP Links, JTM Plukker… - Endocrine …, 2006 - academic.oup.com
The RET gene encodes a receptor tyrosine kinase that is expressed in neural crest-derived
cell lineages. The RET receptor plays a crucial role in regulating cell proliferation, migration …

RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture

M Santoro, RM Melillo, A Fusco - European Journal of …, 2006 - academic.oup.com
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements
that generate the so-called RET/PTC oncogenes. In this review, we examine the data about …

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation

P Ballerini, S Struski, C Cresson, N Prade, S Toujani… - Leukemia, 2012 - nature.com
Myeloproliferative neoplasms are frequently associated with aberrant constitutive tyrosine
kinase (TK) activity resulting from chimaeric fusion genes or point mutations such as BCR …

Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases

P Runeberg‐Roos, M Saarma - Annals of medicine, 2007 - Taylor & Francis
RET (REarranged during Transfection) is a transmembrane receptor tyrosine kinase that is
activated by a complex consisting of a soluble glial cell line‐derived neurotrophic factor …

[HTML][HTML] On the origin of cells and derivation of thyroid cancer: C cell story revisited

M Nilsson, D Williams - European Thyroid Journal, 2016 - etj.bioscientifica.com
We will highlight and put into perspective new lineage tracing data from genetic studies in
mice indicating that the genuine progenitors to C cells arise in the endoderm germ layer …

Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer

T Stepien, R Krupinski, J Sopinski, K Kuzdak… - Archives of medical …, 2010 - Elsevier
BACKGROUND AND AIMS: Vitamin D3, in addition to its role in calcium homeostasis, has
been recognized as playing a role in human cancer development. However, little is known …

RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease

N Asai, M Jijiwa, A Enomoto, K Kawai… - Pathology …, 2006 - Wiley Online Library
Gain‐of‐function mutations within the receptor tyrosine kinase gene RET cause inherited
and non‐inherited thyroid cancer. Somatic gene rearrangements of RET have been found in …

Mechanisms of thyroid development and dysgenesis: an analysis based on developmental stages and concurrent embryonic anatomy

M Nilsson, H Fagman - Current topics in developmental biology, 2013 - Elsevier
Thyroid dysgenesis is the most common cause of congenital hypothyroidism that affects 1 in
3000 newborns. Although a number of pathogenetic mutations in thyroid developmental …

The Tyrosine Kinase Receptor RET Interacts in Vivo with Aryl Hydrocarbon Receptor-Interacting Protein to Alter Survivin Availability

M Vargiolu, D Fusco, I Kurelac… - The Journal of …, 2009 - academic.oup.com
Context: RET is a tyrosine kinase transmembrane receptor expressed in two main
alternative isoforms: RET9 and RET51. RET transduces a positive signal leading to survival …